changing from semaglutide to tirzepatide Switching between weight-loss medications Switching from Semaglutide to Tirzepetide
Description
TriNetX cohort study (547,993 matched adults, published in JAAD International, 2026): GLP1 users were 40 percent more likely to develop nonscarring hair loss, 64 percent more likely to develop pattern thinning, and 76 percent more likely to experience stress-related shedding

Restrained eating scores increased somewhat by the 3rd month, only to return to the baseline values at 12 months

Expired medication may lose its efficacy over time

Several factors, including dosage, adherence to the treatment plan, dietary habits, and overall lifestyle, all play a role in how quickly weight loss occurs

Limited state availability

It may not be safe to order Ozempic from unlicensed sources that arent regulated by the Government of Canada
